Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Berg

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Journal of the American Heart Association|October 28, 2025
Contemporary Practice Patterns of Vasoactive Use in Cardiogenic Shock in the American Heart Association Cardiogenic Shock RegistrySiddharth M Patel, David D Berg, Erin A Bohula, et al.
JACC. Advances|June 28, 2024
Machine Learning Approaches for Phenotyping in Cardiogenic Shock and Critical Illness: Part 2 of 2Jacob C Jentzer, Corbin Rayfield, Sabri Soussi, et al.
JACC. Advances|June 28, 2024
Advances in the Staging and Phenotyping of Cardiogenic Shock: Part 1 of 2Jacob C Jentzer, Corbin Rayfield, Sabri Soussi, et al.
American Journal of Respiratory and Critical Care Medicine|May 16, 2020
A Case of COVID-19 and <i>Pneumocystis jirovecii</i> CoinfectionAravind A Menon, David D Berg, Elliot J Brea, et al.
Diabetes Care|August 9, 2023
Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 DiabetesFilipe A Moura, David D Berg, Andrea Bellavia, et al.
Journal of Thrombosis and Thrombolysis|July 20, 2020
Biomarkers of platelet activation and cardiovascular risk in the DAPT trialDavid D Berg, Robert W Yeh, Laura Mauri, et al.
Journal of the American College of Cardiology|July 26, 2014
Variability of individual platelet reactivity over time in patients treated with clopidogrel: insights from the ELEVATE-TIMI 56 trialWillibald Hochholzer, Christian T Ruff, Robert A Mesa, et al.
ERJ Open Research|December 24, 2025
Effect of budesonide/glycopyrronium/formoterol fumarate dihydrate on cardiopulmonary outcomes in COPD: rationale and design of the THARROS trialFernando J Martinez, John R Hurst, MeiLan K Han, et al.
ESC Heart Failure|September 15, 2025
Galectin-3 and kidney function in type 2 diabetes treated with dapagliflozin: Analysis from DECLARE-TIMI 58Paul M Haller, Stephen D Wiviott, David D Berg, et al.
Journal of the American College of Cardiology|March 19, 2025
Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial FibrillationLars Wallentin, Johan Lindbäck, Ziad Hijazi, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Journal of the American Heart Association|October 28, 2025
Contemporary Practice Patterns of Vasoactive Use in Cardiogenic Shock in the American Heart Association Cardiogenic Shock RegistrySiddharth M Patel, David D Berg, Erin A Bohula, et al.
JACC. Advances|June 28, 2024
Machine Learning Approaches for Phenotyping in Cardiogenic Shock and Critical Illness: Part 2 of 2Jacob C Jentzer, Corbin Rayfield, Sabri Soussi, et al.
JACC. Advances|June 28, 2024
Advances in the Staging and Phenotyping of Cardiogenic Shock: Part 1 of 2Jacob C Jentzer, Corbin Rayfield, Sabri Soussi, et al.
American Journal of Respiratory and Critical Care Medicine|May 16, 2020
A Case of COVID-19 and <i>Pneumocystis jirovecii</i> CoinfectionAravind A Menon, David D Berg, Elliot J Brea, et al.
Diabetes Care|August 9, 2023
Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 DiabetesFilipe A Moura, David D Berg, Andrea Bellavia, et al.
Journal of Thrombosis and Thrombolysis|July 20, 2020
Biomarkers of platelet activation and cardiovascular risk in the DAPT trialDavid D Berg, Robert W Yeh, Laura Mauri, et al.
Journal of the American College of Cardiology|July 26, 2014
Variability of individual platelet reactivity over time in patients treated with clopidogrel: insights from the ELEVATE-TIMI 56 trialWillibald Hochholzer, Christian T Ruff, Robert A Mesa, et al.
ERJ Open Research|December 24, 2025
Effect of budesonide/glycopyrronium/formoterol fumarate dihydrate on cardiopulmonary outcomes in COPD: rationale and design of the THARROS trialFernando J Martinez, John R Hurst, MeiLan K Han, et al.
ESC Heart Failure|September 15, 2025
Galectin-3 and kidney function in type 2 diabetes treated with dapagliflozin: Analysis from DECLARE-TIMI 58Paul M Haller, Stephen D Wiviott, David D Berg, et al.
Journal of the American College of Cardiology|March 19, 2025
Biomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial FibrillationLars Wallentin, Johan Lindbäck, Ziad Hijazi, et al.
Pageof 13